Re-Treatment With 177Lu-DOTATATE in Patients With Neuroendocrine Tumors: Multicenter Real-World Experience

被引：0
|
作者：
Navalkissoor, S. [1 ]
Essler, M. [2 ]
Caplin, M. [1 ]
Van Der Zwan, W. [3 ]
Wicharz, M. [2 ]
De Herder, W. [3 ]
Broberg, P. [4 ]
Krenning, E. [3 ]
机构：
[1] Royal Free London NHS Fdn Trust, London, England
[2] Univ Klinikum Bonn, Bonn, Germany
[3] Erasmus MC, Rotterdam, Netherlands
[4] Adv Accelerator Applicat, Geneva, Switzerland
来源：
PANCREAS | 2021年 / 50卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
C-27
引用
收藏
页码：453 / 453
页数：1
相关论文
共 50 条
  • [21] Therapeutic response evaluation in patients with neuroendocrine tumors treated with 177Lu-DOTATATE
    Gupta, Santosh
    Damle, Nishikant
    Bal, Chandrasekhar
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [22] Early prediction of the efficacy of 177Lu-DOTATATE in patients with metastatic neuroendocrine tumors
    Bando-Delaunay, A.
    de Rycke, O.
    Hentic, O.
    Leclerc, P.
    Allouch, A.
    Cros, J.
    Rebours, V
    Ruszniewski, P.
    Lebtahi, R.
    de Mestier, L.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 176 - 176
  • [23] Prognostic factors in patients with advanced neuroendocrine tumors treated with 177Lu-DOTATATE
    Casanovas, M. Mitjavila
    Percovich, J.
    Bello, P.
    Arbizu, J.
    Pubul, V.
    Riesco, M.
    Muros, M.
    Gonzalez, E.
    Carmona-Bayonas, A.
    Estenoz, J.
    Rotger, A.
    Llana, B.
    Aller, J.
    Jimenez-Fonseca, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S593 - S594
  • [24] Dosimetry of 177Lu-DOTATATE administered into neuroendocrine tumors - An initial experience from India
    Gupta, Santosh
    Meera, V
    Malhotra, A.
    Kumar, Prateek
    Bal, Chandersekhar
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [25] Case Report: Re-Treatment With Lu-DOTATATE in Neuroendocrine Tumors
    Vida Navas, Elena Maria
    Martinez Lorca, Alberto
    Sancho Gutierrez, Aintzane
    Sanz Gomez, Lucia
    Navarro Martinez, Teresa
    Grande Pulido, Enrique
    Carrato Mena, Alfredo
    Gajate Borau, Pablo
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [26] Experience with 177Lu-Dotatate in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors at a Single Urban Cancer Center
    Kieft, A. L.
    Ibrahim, Y.
    Dyson, G.
    Baran, G.
    Azmi, A.
    Al Hallak, M. N.
    Shields, A. F.
    Vaishampayan, N. G.
    Philip, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E307 - E308
  • [27] Neoadjuvant treatment with 177Lu-DOTATATE for nonfunctional neuroendocrine tumors of the pancreas (NEOLUPANET): a multicenter phase II study
    Mintziras, Ioannis
    Bartsch, Detlef K.
    CHIRURGIE, 2025, 96 (01): : 63 - 64
  • [28] 177-Lu-DOTATATE in 200 Patients with Neuroendocrine Tumors: Real-World Data from the SEPTRALU Registry
    Carmona-Bayonas, A.
    Mitjavila, Casanovas M.
    Bello, P.
    Percovich, J. C.
    Prieto, A.
    Arbizu, J.
    Field, C.
    Muro, M. A.
    Del Olmo, M. C.
    Castellon, M.
    Pubul, V
    Jimenez-Fonseca, P.
    NEUROENDOCRINOLOGY, 2020, 110 : 251 - 251
  • [29] Real- world efficacy and safety of re-treatment with [177Lu] Lu-DOTA-TATE in patients with neuroendocrine tumors (NETs)
    Martinez Lago, N. P.
    Hernando Cubero, J.
    Calatayud, A.
    Velazquez, F.
    Anido, U.
    Garcia-Alvarez, A.
    de Matias Leralta, J. M.
    Asadurova, S.
    Cabezas Agricola, J. M.
    Garcia Burillo, D.
    Pubul Nunez, V
    Capdevila, J.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 208 - 208
  • [30] Treatment with the Radiolabelled Somatostatin Analog 177Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
    Sansovini, Maddalena
    Severi, Stefano
    Ambrosetti, Alice
    Monti, Manuela
    Nanni, Oriana
    Sarnelli, Anna
    Bodei, Lisa
    Garaboldi, Lucia
    Bartolomei, Mirco
    Paganelli, Giovanni
    NEUROENDOCRINOLOGY, 2013, 97 (04) : 347 - 354
12345